Gene expression studies have suggested that dopamine (DA) depletion increases the sensitivity of striatal direct pathway neurons to the effects of serotonin (5-HT) via the 5-HT 2 receptor. The present study examined the possible influence(s) of 5-HT 2A or 5-HT 2C receptor-mediated signaling locally within the striatum on motor behavior triggered by 5-HT 2 receptor agonism in the neonatal DA-depleted rat. Male Sprague-Dawley rats were treated with 6-hydroxydopamine (6-OHDA; 60 µg in 5 µl per lateral ventricle) on postnatal day 3 to achieve near-total DA depletion bilaterally. Sixty days later, sham-operated (saline-injected) or 6-OHDA-treated rats were challenged with the 5-HT 2A/2C agonist DOI ((±)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane) or saline either by systemic treatment or bilateral intrastriatal infusion. Motor behavior was quantified for 60 min after agonist injection using computerized activity monitors. Systemic DOI treatment (0.2-2.0 mg/kg ip) was more effective in inducing motor activity in the DA-depleted group as compared to intact controls.
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development results in a compensatory increase in serotonin (5-HT) innervation to the dorsal striatum (Breese et al., 1984; Stachowiak et al., 1984) . The "5-HT hyperinnervation" phenomenon arises from raphestriatal axons that normally provide heavier 5-HT innervation to the caudal striatum, but sprout collaterals to the more sparsely innervated rostral striatum in response to neonatal DA depletion (Berger et al., 1985; Snyder et al., 1986; Luthman et al., 1987; Towle et al., 1989) . Though this plasticity leads to a doubling of [ 3 H]5-HT-labeled axonal varicosities (Mrini et al., 1995) , they do not form new synapses in significant numbers (Descarries et al., 1992) . Rather, sprouted axons appear to accumulate significant amounts of 5-HT (Molina-Holgado et al., 1994) so that extracellular 5-HT levels are tripled under stimulatory release conditions (Jackson and Abercrombie, 1992) .
Several studies indicate that 5-HT 2A receptors are positioned to mediate the influences of enhanced 5-HT signaling in the DA-depleted striatum. First, 5-HT release agents and 5-HT 2 receptor agonists gain potency in inducing striatal preprotachykinin (PPT; encodes substance P and neurokinin A gene expression within the direct striatal output pathway) under conditions of DA depletion (Gresch and Walker, 1999; Basura and Walker, 2000, 2001) . Second, 5-HT 2 receptor-mediated signaling appears to contribute to spontaneous hyperactivity observed in neonatal DA-depleted rats (Luthman et al., 1991) and also fosters D 1 receptor-mediated hyperlocomotive behaviors following adult DA lesions (Bishop et al., 2003; Bishop and Walker, 2003) . Third, similar to the 5-HT sprouting phenomenon, the 5-HT 2A receptor is more heavily expressed within the dorsal striatum following neonatal DA depletion (Radja et al., 1993 ;
hypothesize that 5-HT 2A receptor stimulation may underlie hyperlocomotive behaviors in the DA-depleted rat.
The present study examined the effects of 5-HT 2 receptor agonism on motor behaviors expressed in adult rats that had received bilateral DA lesions as neonates. Although 5-HT 2 receptor agonists such as DOI produce minimal effects on locomotor behavior in the intact rat (Koskinen et al., 2000) , we predicted that systemic DOI treatments would increase locomotor behaviors in 6-OHDA-treated rats since 5-HT 2 receptor stimulation has previously been shown to gain potency in regulating direct pathway gene expression (Gresch and Walker, 1999; Basura and Walker, 2001) . In order to limit the effects of DOI to the striatal region that demonstrates prominent 5-HT 2A receptor plasticity, we measured behavior in response to local DOI infusion into the dorsal striatum of intact and DA-depleted groups. These latter experiments also included the co-infusion of selective antagonists M100907 (Kehne et al., 1996; Johnson et al., 1996) and RS102221 (Bonhaus et al., 1997) to discern the effects of local striatal 5-HT 2A vs 5-HT 2C receptor activation, respectively, on DOI-induced motor activity. The results obtained suggest that 5-HT 2A receptor plasticity within the dorsal striatum is functionally significant and may influence motor control mechanisms of the DA-depleted rodent. NIH publication number 85-23, revised 1996) . Rat pups arrived on postnatal day 2 and were initially group-housed (n=12/dam) in plastic cages (22 cm high, 45 cm deep and 23 cm wide) within a temperature controlled colony room (22-23°C) illuminated on a 12 h light/dark cycle (lights on 0700 h). Once rats were 3 weeks old, they were weaned from the dams, group-housed (4-5/cage) and fed standard lab chow (Rodent Diet 5001; LabDiet, Brentwood, MO) and water which were available throughout the remainder of the experiment.
6-hydroxydopamine (6-OHDA) lesions and cannulae implantation surgeries. Bilateral intracerebroventricular (icv) 6-OHDA lesions were performed as reported previously (Basura and Walker, 1999) . On postnatal day 3, rat pups were anesthetized to effect by hypothermia (body immersion in a foil chamber cooled in wet ice) and a midsagittal incision was made on the dorsal scalp to reveal the skull sutures and obtain reference coordinates from Bregma. Each rat received a bilateral infusion of 6-OHDA (60 µg; Sigma, St. Louis, MO) or its vehicle solution of saline containing 0.1% ascorbic acid (Sigma) at a rate of 5 µl over 30 sec into each ventricle (AP 0.0 mm, ML ±1.0 mm, DV -2.5 mm relative to Bregma) using a 10 µl syringe equipped with a 30 gauge needle. Pups were placed under a heat lamp for recovery prior to being returned to the mother rat. All rats received subcutaneous injections of desipramine (25 mg/kg; Sigma) 30 min prior to surgery to protect norepinephrine neurons. Sixty days following icv lesions, rats were anesthetized with an intraperitoneal (ip) injection of ketamine (90 mg/kg; Lloyd Laboratories, This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on March 25, 2004 as DOI: 10.1124 at ASPET Journals on July 7, 2017 jpet.aspetjournals.org Downloaded from Shenandoah, IO) and xylazine (15 mg/kg; Lloyd Laboratories) mixture and implanted bilaterally with chronic 22 gauge intracranial guide cannulae (C313G/SPC; Plastics One Inc., Roanoke, VA). With the incisor bar positioned 3.3 mm below the interaural line, cannulae were positioned above the dorsal striatum bilaterally using the coordinates AP +0.4 mm, ML ±2.9 mm and DV -3.6 mm relative to bregma (Paxinos and Watson, 1998) . Cannulae were fixed in place using liquid and powder dental acrylic (Lang Dental, Wheeling, IL) . At the completion of surgery, guide cannulae were fitted with 28 gauge inner stylets (Plastics One) to maintain patency.
Pharmacological treatments.
The following 5-HT 2 receptor agents were used in this study: Behavioral procedure. Locomotor activity monitoring was conducted in 6 identical acrylic chambers measuring 40 cm long, 40 cm wide and 30 cm high (Accuscan Instruments, Columbus, OH). Each chamber was surrounded by a 15x15 infrared photocell array interfaced with a computer that ran the Versamax and Versadat programs (Accuscan Instruments). These programs tabulated and processed a number of variables related to locomotor behavior. For the present experiment the variables collected over twenty 3 min periods were horizontal activity (beam breaks counted across the photocell array), distance traveled (in centimeters), movement bouts (number of times a rat ended and then initiated another movement period), stereotypy activity (beam breaks counted at the same photocell array) and stereotypy bouts (number of times a rat ended and then initiated another stereotypy period). Prior to experimentation, rats were acclimated to the behavioral procedure at least 3 times. All testing occurred between 0830-1230 h. On testing days, rats were placed in the activity chambers for 30 min before injections commenced. During injections, rats were lightly restrained with a towel and 15 mm 30 gauge injectors (Plastics One) were slowly lowered to extend 1 mm past the end of the guide cannulae.
Once injectors were in place, drug was infused at a rate of 0.63 µl/min by a microinfusion pump (Harvard Apparatus, Boston, MA) that held two-50 µl Hamilton syringes attached to plastic tubing (PE20 Tygon tubing; Plastics One) and the injectors. Following infusions, injectors remained in place for 30 sec. Immediately after the injectors were removed, the pump was restarted and injectors were inspected for fluid expulsion. Tissue dissection and cryostat sectioning. When experiments were completed, rats were sacrificed by decapitation and brains were immediately removed and dissected. Tissue from 20 randomly selected rats (10 control, 10 6-OHDA lesions) was used solely for histological examination. To accomplish this, the region surrounding the injection sites was blocked and rapidly frozen in isopentane (-30° C) and stored at -80° C. Cresyl violet (FD Neurotechnologies, Baltimore, MD) staining was used to determine injection sites and neuronal viability from cryostat-generated 12 µm coronal sections surrounding the cannulae placements that were postfixed with 4% paraformaldehyde (Fisher Scientific, Hanover Park, IL). In another randomly selected set of control (n=13) and 6-OHDA-lesioned rats (n=13), striata were freshly dissected +0.5 mm to -0.5 mm around the injection site, frozen at -80° C and later subjected to monoamine analysis using high performance liquid chromatography with electrochemical detection (HPLC-ED) to determine levels of DA depletion.
HPLC Analysis. HPLC-ED was performed on striatal tissue as previously described (Gresch and Walker, 1999) 
Results
Representative Histology. Fig. 1 shows a schematic representation of a coronal brain section (Paxinos and Watson, 1998) located 0.48 mm anterior to Bregma illustrating placements for control (unfilled ovals) and 6-OHDA lesioned (filled ovals) rats included in the study. All rats analyzed were found to have injector placements within the dorsal aspects of the striatum.
Monoamine and metabolite levels. As shown in Table 1 , HPLC analyses revealed a significant decline in striatal DA (-98%) and DOPAC (-94%) levels in the 6-OHDA-injected group as compared to intact control rats while DOPAC/DA ratio increased +313% indicating heightened DA turnover in a small percentage of surviving DA terminals. Increased 5-HT (+95%) and 5-HIAA (+82%) levels were indicative of the 5-HT hyperinnervation phenomenon, but 5-HIAA/5-HT ratios remained at control levels. Norepinephrine amounts in lesioned striata were not significantly different from controls. Such results are consistent with our previous studies (Basura and Walker, 2000 and Walker, , 2001 Campbell et al., 2001 ).
Locomotor effects of systemic DOI. Peripheral administration of 5-HT 2 receptor agonists has been reported to have subtle but significant effects on motor activity (Willins and Meltzer, 1997) . To this point however, it is not known whether DA depletion modifies these effects. In the present study, systemic administration of DOI produced a number of dose-dependent effects on locomotor behavior that were enhanced by 6-OHDA lesions (Fig. 2) Effects of intrastriatal 5-HT 2 agonism on locomotor behavior. To determine if the effects of systemic DOI treatment may have been mediated by neurons of the striatum, we infused DOI into the dorsal striatum of control and neonate 6-OHDA-lesioned rats (Fig. 3) . Initial analyses across the entire 60 min post-infusion period yielded no treatment effects (data not shown), however, it was noted that during the 2 nd 30 min of measurement, DOI-treated rats appeared more active. As such, data reported here represent means for the 2 nd 30 min of treatment. Stereotypy activity where no differences were found with the 10 µg dose of DOI. rats (Fig. 4) . 
Effects of 5-HT

Discussion
The present study showed that systemic 5-HT 2 agonist treatment more potently stimulates motor activity within DA-depleted rats as compared to intact controls. When DOI was confined to the striatum via local infusion, hyperactivity was again observed in DA-depleted rats, but not in intact controls. The locomotor effects of intrastriatal DOI were completely suppressed by co- In the intact rat, a well-characterized motoric behavior induced by systemic DOI treatment is the head-twitch response (Darmani et al., 1992) , now known to be mediated by 5-HT 2A receptors of the medial prefrontal cortex (Willins and Meltzer, 1997) . In contrast, systemic DOI alone seems to produce only modest effects on locomotor behavior (Koskinen et al., 2000) . Such It is interesting that neither low nor high doses of DOI induced a behavioral change in the intact animal following intrastriatal infusion in the present study. This result is not surprising given the fact that the rostral striatum exhibits weak DOI binding under normal conditions (McKenna et al., 1989; Appel et al., 1990) . In agreement, direct pathway expression of PPT mRNA was unaffected in the rostral striatum following systemic DOI treatment, but was increased in the caudal striatum where 5-HT 2A receptors are more heavily expressed (Walker et al., 1996; Gresch and Walker, 1999; Basura and Walker, 2001) . Thus, although DOI may not be a strong regulator of locomotor behavior controlled by direct pathway neurons of the intact rostral striatum, it may have a greater influence if placed into the caudal striatum where PPT mRNA is more readily induced by this agonist. In contrast to the results of intrastriatal DOI infusions in the intact animal, the present study found that both low and high DOI doses induced locomotor and stereotypic behavior when infused into the rostral striatum of DA-depleted rats.
This result is consistent with our previous observations that DOI provided a more effective regulation of striatal PPT mRNA expression in DA-depleted animals (Gresch and Walker, 1999; Basura and Walker, 2001 (Radja et al., 1993; Laprade et al., 1996; Basura and Walker, 1999) , may provide the means for the enhanced actions of DOI within the DA-depleted striatum. Together, these results strengthen our hypothesis that motor behavior induced in DA-depleted rats following local striatal 5-HT 2 receptor stimulation involves the activation of the direct striatal output pathway.
This article has not been copyedited and formatted. The final version may differ from this version. Antagonists were included in the design of this study that have nanomolar binding affinities for 5-HT 2A vs 5-HT 2C receptors with 100-fold selectivity in discriminating each subtype Kehne et al., 1996; Bonhaus et al., 1997) . Although the present study did not determine if antagonist concentrations within the injection site were in the range that would ensure selectivity, results showing the differential blocking effects of each antagonist help discern which receptor is likely involved in DOI-induced motor activities. Such data are important because although (±)-DOI binds selectively to 5-HT 2 receptors, this agonist is unable to discriminate between 5-HT 2A and 5-HT 2C subtypes (McKenna et al., 1989; Appel et al., 1990 ).
Though 5-HT 2C receptors do not appear to be increased within the striatum in response to DA depletion (Basura and Walker, 1999), they are thought to provide significant regulation of signal transduction when stimulated (Wolf and Schutz, 1997). Interestingly, 5-HT 2C antagonists administered locally into the substantia nigra have been shown to potentiate movements induced by DA receptor agonists in the DA-depleted rat (Fox et al., 1998) . However, intrastriatal infusion of the selective 5-HT 2C antagonist RS102221 (Bonhaus et al., 1997 ) had no effect on motor activity in the present study while ketanserin and M100907 both suppressed DOI-induced movements in DA-depleted rats. Ketanserin was originally developed as a selective 5-HT 2 receptor antagonist, but it is also known to possess significant histamine and α1-adrenergic binding properties (Leysen et al., 1982) . However, ketanserin is still useful to help discriminate between 5-HT 2 subtypes since it demonstrates superior antagonist properties at 5-HT 2A vs 5-HT 2C receptors (Jerman et al., 2001) . The more recent development of M100907 (formerly MDL 100,907) has aided in further delineation of 5-HT 2 receptor subtypes since it binds the 5-HT 2A receptor with sub-nanomolar affinity in contrast to moderate-to-low (>100 fold separation) affinity at the 5-HT 2C and α 1 -adrenergic sites and >500 fold separation from D 2 receptor binding This article has not been copyedited and formatted. The final version may differ from this version. (Kehne et al., 1996; Johnson et al., 1996) . Thus, our observations that two 5-HT 2A receptor
antagonists showed blocking effects while a 5-HT 2C receptor antagonist was without effect supports our hypothesis that a strengthened 5-HT 2A receptor system underlies the ability of intrastriatal DOI to produce movement in the DA-depleted rat. In accordance with these results, previous studies demonstrated that ketanserin suppressed the effects of systemic DOI treatment on striatal PPT mRNA induction in the DA-depleted rat (Basura and Walker, 2001 ).
Finally, although the present findings were uncovered in rodents, the results obtained may have relevance to human disorders of movement. Since the triggering mechanism for striatal 5-HT 2A receptor plasticity in rodents is DA depletion and not 5-HT sprouting (Laprade et al., 1996; Basura and Walker, 1999) , enhanced 5-HT 2A receptor signaling may influence striatal function in adult disorders that deplete DA, but do not necessarily induce the 5-HT hyperinnervation phenomenon. It may be significant that 5-HT 2A receptors are intensely expressed within striosomes of the human caudate nucleus and putamen (Waeber and Palacios, 1994; LopezGimenez et al., 1999) and thus may play a prominent role in the regulation of striatal function.
Such approximation may be considered relevant when considering the possibility that oversensitive 5-HT 2A receptors may contribute to unwanted movements, such as dyskinesias that develop in response to levodopa treatment in Parkinson's disease or excessive behaviors that accompany attention-deficit hyperactivity disorder. Indeed, recent evidence obtained from DAdepleted rodents suggests that striatal 5-HT 2A receptor plasticity contributes to abnormal movements in response to intrastriatal D 1 receptor stimulation (Bishop et al., 2003; Bishop and Walker, 2003) . Therefore, although the phenomenon of 5-HT 2A receptor plasticity has been known for some years in rodents, the most interesting findings relevant to human movement disorders are yet to be revealed. Values are nanogram monoamine or metabolite per milligram protein or ratios of metabolite to monoamine (mean ± S.E.) with percent of vehicle group in parentheses. Differences between group means were determined by independent 2-tailed t-tests (*p<0.05 compared to vehicle group).
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